however , duodenal ulcer relapse rates always exceed 20 percent and frequently approach 50 percent , whether the therapy be h2-receptor antagonists or sucralfate , and the use of dosages that are half the healing dose seems irrational .
C0013295
duodenal ulcer
C0038633
sucralfate